bq 610 has been researched along with catechol in 1 studies
Studies (bq 610) | Trials (bq 610) | Recent Studies (post-2010) (bq 610) | Studies (catechol) | Trials (catechol) | Recent Studies (post-2010) (catechol) |
---|---|---|---|---|---|
124 | 1 | 3 | 2,175 | 5 | 867 |
Protein | Taxonomy | bq 610 (IC50) | catechol (IC50) |
---|---|---|---|
Carbonic anhydrase 1 | Homo sapiens (human) | 5.79 | |
Carbonic anhydrase 2 | Homo sapiens (human) | 5.79 | |
Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 0.868 | |
Carbonic anhydrase 6 | Homo sapiens (human) | 5.79 | |
Glutaminyl-peptide cyclotransferase | Homo sapiens (human) | 5 | |
Carbonic anhydrase 3 | Bos taurus (cattle) | 5.79 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asico, LD; Bek, M; Eisner, GM; Goldstein, DS; Grandy, DK; Jose, PA; Li, XX; Rubinstein, M; Yang, Z | 1 |
1 other study(ies) available for bq 610 and catechol
Article | Year |
---|---|
Adrenergic and endothelin B receptor-dependent hypertension in dopamine receptor type-2 knockout mice.
Topics: Adrenergic alpha-Antagonists; Angiotensin Receptor Antagonists; Animals; Antidiuretic Hormone Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Body Weight; Catechols; Endothelin Receptor Antagonists; Endothelin-1; Female; Genotype; Hypertension; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; Oligopeptides; Phentolamine; Piperidines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Adrenergic; Receptors, Dopamine D2; Receptors, Endothelin; Sodium; Sodium-Potassium-Exchanging ATPase; Urodynamics; Viper Venoms | 2001 |